- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
**Financial Highlights:** Navin Fluorine International Limited reported robust financial performance for Q3 FY25, achieving sales of ₹606.2 Cr, reflecting a 21% year-on-year increase. Operating EBITDA surged 95% YoY to ₹147.3 Cr, with a margin improvement of 917 basis points to 24.3%. Profit Before Tax (PBT) rose dramatically by 195% YoY, totaling ₹97.5 Cr. For the nine-month period, sales totaled ₹1,648.4 Cr, up 13% YoY, with operating EBITDA at ₹355.0 Cr, marking a 23% increase.
**Strategic Initiatives and Growth Drivers:** The company is on track with significant capex projects, including ₹450 Cr for new HF capacity expected by early FY26 and ₹84 Cr for R32 capacity set for commissioning in February 2025. Strong demand visibility for HPP and specialty chemical products bodes well for future growth.
**Business Developments:** Navin continues to engage in strategic partnerships, securing multi-year contracts in agrochemicals and maintaining robust order books, particularly in European markets.
**Market Position and Competitive Advantage:** With over 50 years of expertise and state-of-the-art facilities, Navin is positioned as a leading player in specialty fluorochemicals with plans for significant capacity enhancements.
**Investor Implications:** A positive outlook is projected due to strong operational performance, strategic growth plans, and ongoing expansion initiatives. Investors should monitor upcoming production capacities and partnership developments closely.